Environmental enteric dysfunction is associated with altered bile acid metabolism

Journal of Pediatric Gastroenterology and Nutrition

Volumn 64, Issue 4, 2017, Pages 536-540

  Semba, Richard D ^a   Gonzalez Freire, Marta ^b   Moaddel, Ruin ^b   Trehan, Indi ^c,d   Maleta, Kenneth M ^d   Khadeer, Mohammed ^b   Ordiz, Maria Isabel ^c   Ferrucci, Luigi ^b   Manary, Mark J ^c,d  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF MALAWI   (Malawi)

Author keywords

Africa; children; malabsorption; malnutrition

Indexed keywords

BILE ACID; BILE ACID CONJUGATE; CHENODEOXYCHOLIC ACID; CHOLIC ACID; GLYCINE; GLYCOCHOLIC ACID; GLYCODEOXYCHOLIC ACID; GLYCOLITHOCHOLIC ACID; GLYCOURSODEOXYCHOLIC ACID; STABLE ISOTOPE; SUGAR; TAURINE; TAUROCHENODEOXYCHOLIC ACID; TAURODEOXYCHOLIC ACID; TAUROMURICHOLIC ACID; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

AGE; AMINO ACID BLOOD LEVEL; ARTICLE; BILE ACID BLOOD LEVEL; BILE ACID METABOLISM; CHILD; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL DISEASE; FEMALE; HUMAN; INTESTINE FUNCTION DISORDER; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MAJOR CLINICAL STUDY; MALAWI; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RURAL AREA; BLOOD; CASE CONTROL STUDY; DEVELOPING COUNTRY; INFANT; LIQUID CHROMATOGRAPHY; MALABSORPTION; METABOLISM; RURAL HEALTH; SMALL INTESTINE; TANDEM MASS SPECTROMETRY;

BILE ACIDS AND SALTS; BIOMARKERS; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CHROMATOGRAPHY, LIQUID; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; FEMALE; HUMANS; INFANT; INTESTINE, SMALL; MALABSORPTION SYNDROMES; MALAWI; MALE; RURAL HEALTH; TANDEM MASS SPECTROMETRY;

EID: 84975469625     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000001313     Document Type: Article

References (23)

1. Keusch GT, Denno DM, Black RE, et al. Environmental enteric dysfunction: pathogenesis, diagnosis, and clinical consequences. Clin Infect Dis 2014;59(suppl 4):S207-12.
2. Lunn PG, Northrop-Clewes CA, Downes RM. Intestinal permeability, mucosal injury, and growth faltering in Gambian infants. Lancet 1991;338:907-10.
3. Weisz AJ, Manary MJ, Stephenson K, et al. Abnormal gut integrity is associated with reduced linear growth in rural Malawian children. J Pediatr Gastroenterol Nutr 2012;55:747-50.
4. Veitch AM, Kelly P, Zulu IS, et al. Tropical enteropathy: a T-cellmediated crypt hyperplastic enteropathy. Eur J Gastroenterol Hepatol 2001;13:1175-81.
5. Campbell DI, Murch SH, Elia M, et al. Chronic T cell-mediated enteropathy in rural west African children: relationship with nutritional status and small bowel function. Pediatr Res 2003;54:306-11.
6. Dawson PA, Karpen SJ. Intestinal transport and metabolism of bile acids. J Lipid Res 2015;56:1085-99.
7. Erickson RA, Epsten RJ Jr. Oral chenodeoxycholic acid increases small intestinal permeability to lactulose in humans. Am J Gastroenterol 1988;83:541-4.
8. Munch A, Strom M, Soderholm JD. Dihydroxy bile acids increase mucosal permeability and bacterial uptake in human colon biopsies. Scand J Gastroenterol 2007;42:1167-74.
9. Chen X, Oshima T, Tomita T, et al. Acidic bile salts modulate the squamous epithelial barrier function by modulating tight junction proteins. Am J Physiol Gastrointest Liver Physiol 2011;301:G203-9.
10. Stenman LK, Holma R, Eggert A, et al. A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids. Am J Physiol Gastrointest Liver Physiol 2013;304:G227- 34.
11. de Onis M, Onyango A, Borghi E, et al. Worldwide implementation of the WHO Child Growth Standards. Public Health Nutr 2012;15:1603-10.
12. Denno DM, VanBuskirk K, Nelson ZC, et al. Use of the lactulose to mannitol ratio to evaluate childhood environmental enteric dysfunction: a systematic review. Clin Infect Dis 2014;59(suppl 4):S213-9.
13. Lord RS, Bralley JA (Eds): Laboratory Evaluations for Integrative and Functional Medicine. Duluth, Georgia: Metametrix Institute; 2008.
14. Schmerler D, Neugebauer S, Ludewig K, et al. Targeted metabolomics for discrimination of systemic inflammatory disorders in critically ill patients. J Lipid Res 2012;53:1369-75.
15. Hylemon PB, Zhou H, Pandak WM, et al. Bile acids as regulatory molecules. J Lipid Res 2009;50:1509-20.
16. Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 2003;72:137-74.
17. Jahnel J, Zohrer E, Scharnagl H, et al. Reference ranges of serum bile acids in children and adolescents. Clin Chem Lab Med 2015;53:1807- 13.
18. Fiorucci S, Distrutti E. Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders. Trends Mol Med 2015;21:702-14.
19. Smith MI, Yatsunenko T, Manary MJ, et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 2013;339:548-54.
20. Brown EM, Wlodarska M,Willing BP, et al. Diet and specific microbial exposure trigger features of environmental enteropathy in a novel murine model. Nat Commun 2015;6:7806.
21. Bolt MJ, Stellaard F, Sitrin MD, et al. Serum unconjugated bile acids in patients with small bowel bacterial overgrowth. Clin Chim Acta 1989;181:87-101.
22. Trehan I, Shulman RJ, Ou CN, et al. A randomized, double-blind, placebo-controlled trial of rifaximin, a nonabsorbable antibiotic, in the treatment of tropical enteropathy. Am J Gastroenterol 2009;104:2326-33.
23. Schneider SM, Joly F, Gehrardt MF, et al. Taurine status and response to intravenous taurine supplementation in adults with short-bowel syndrome undergoing long-term parenteral nutrition: a pilot study. Br J Nutr 2006;96:365-70.